Diagnostics and Tools July 2024

Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.

Highlights from this edition:

• Eurobio Scientific was acquired by MBK Partners
• Astorg announced its acquisition of Hamilton Thorne
• CytoReason closed a $80MM Series A Financing, led by NVDIA Corporation, Thermo Fisher Scientific, Pfizer Inc, OurCrowd Ltd